The CDC reports an increase in respiratory syncytial virus (RSV) cases among young children and babies; the deadline looms for reauthorizing the United States’ global AIDS program as it has become a topic within the abortion debate; an eye-tracking device may help to diagnose autism spectrum disorder earlier.
RSV Cases Rise Among Young Children and Babies
The CDC has alerted doctors about a rise in respiratory syncytial virus (RSV) cases among young children and babies in Georgia and Florida, according to CNN. The late-summer increase suggests that RSV is falling into a typical seasonal pattern after several years of early viral activity caused by the pandemic. The CDC reported that from August 5 to 19, RSV-related hospitalizations increased from 2 in 100,000 kids aged 4 and younger to 7 per 100,000, the majority of which were in babies younger than 1 year. Doctors have been advised by the CDC to be ready with a new RSV vaccine for young children to help prevent them from developing the infection.
Global AIDS Program Deadline Looms With No Deal in Sight
Congress is likely to blow past a September 30 deadline to reauthorize the law that governs PEPFAR (President's Emergency Plan for AIDS Relief), the United States’ global HIV/AIDS relief work, as it has become a topic within the fight over abortion, according to Politico. Members of both parties do not see a clear path to reviving the law by the end of the year because of competing interests. For example, Republican House members and conservative advocates allege that some of PEPFAR’s annual budget of nearly $7 billion flows to abortion providers, which the Biden administration, program leaders, and outside experts deny.
Potential Earlier Autism Diagnosis With Eye-Tracking Device
A device that follows kids’ eye movements while watching a video of 2 children interacting may help diagnose autism spectrum disorder earlier, according to NBC News. Studies suggest that the tablet-based device can identify autism in children aged 16 to 30 months as accurately as a specialist. It monitors the video viewer’s eye movements at a rate of 120 times a second, allowing specialists to determine what social information children are taking in; typically developing children focus on the interaction while those with autism focus on other spots in the video. With this device, results can be available in 30 minutes.
Leveraging AI and Community Health Workers to Boost Trial Access
January 4th 2025In this second part of our interview with Kasey Bond, MPH, NYU Langone Health, we discuss the contributions of community health workers to increasing clinical trial access and how technology—artificial intelligence (AI), in particular—can help to facilitate the process.
Read More
Frameworks for Advancing Health Equity: Pharmacy Support for Non-Hodgkin Lymphoma
December 19th 2024Rachael Drake, pharmacy technician coordinator, University of Kansas Health System, explains how her team collaborates with insurance companies and providers to support treatment access for patients with non-Hodgkin lymphoma.
Listen
AI in Oncology: Opportunities and Challenges for NSCLC
January 1st 2025Ryan Nguyen, DO, University of Illinois Chicago, highlights the importance of personalized care for patients who have non–small cell lung cancer (NSCLC) and the potential of artificial intelligence (AI) in oncology, while cautioning against its limitations, including the risk of unsupported recommendations.
Read More
ICYMI: Highlights From AMCP Nexus 2024
December 26th 2024Check out this year's top coverage from The Academy of Managed Care Pharmacy (AMCP) Nexus 2024 meeting, which included relevant topics in health care policy, novel pharmaceutical developments, financial considerations across multiple conditions, and more.
Read More